Literature DB >> 29429892

Osteosarcoma subtypes: Magnetic resonance and quantitative diffusion weighted imaging criteria.

Rania Zeitoun1, Ahmed M Shokry2, Sahar Ahmed Khaleel3, Shaimaa M Mogahed4.   

Abstract

INTRODUCTION: Osteosarcoma (OS) is a primary bone malignancy, characterized by spindle cells producing osteoid. The objective of this study is to describe the magnetic resonance imaging (MRI) features of different OS subtypes, record their attenuation diffusion coefficient (ADC) values and to point to the relation of their pathologic base and their corresponding ADC value. PATIENTS AND METHODS: We performed a retrospective observational lesion-based analysis for 31 pathologically proven osteosarcoma subtypes: osteoblastic (n = 9), fibroblastic (n = 8), chondroblastic (n = 6), para-osteal (n = 3), periosteal (n = 1), telangiectatic (n = 2), small cell (n = 1) and extra-skeletal (n = 1). On conventional images we recorded: bone of origin, epicenter, intra-articular extension, and invasion of articulating bones, skip lesions, distant metastases, pathological fractures, ossified matrix, hemorrhage and necrosis. We measured the mean ADC value for each lesion.
RESULTS: Among the included OS lesions, 51.6% originated at the femur, 29% showed intra-articular extension, 16% invaded neighboring bone, 9% were associated with pathological fracture and 25.8% were associated with distant metastases. On MRI, all lesions showed ossified matrix, 35.5% showed hemorrhage and 58% showed necrosis. The mean ADC values for OS lesions ranged from 0.74 × 10-3 mm2/s (recorded for conventional osteoblastic OS) to 1.50 × 10-3 mm2/s (recorded for telangiectatic OS) with an average value of 1.16 ± 0.18 × 10-3 mm2/s. Conventional chondroblastic OS recorded higher values compared to the other two conventional subtypes.
CONCLUSION: Osteosarcoma has different pathologic subtypes which correspondingly vary in their imaging criteria and their ADC values.
Copyright © 2018. Production and hosting by Elsevier B.V.

Entities:  

Keywords:  ADC value; Diffusion weighted imaging; Magnetic resonance imaging; Osteosarcoma; Osteosarcoma subtypes

Mesh:

Year:  2018        PMID: 29429892     DOI: 10.1016/j.jnci.2018.01.006

Source DB:  PubMed          Journal:  J Egypt Natl Canc Inst        ISSN: 1110-0362


  5 in total

Review 1.  Pediatric skeletal diffusion-weighted magnetic resonance imaging, part 2: current and emerging applications.

Authors:  Apeksha Chaturvedi
Journal:  Pediatr Radiol       Date:  2021-05-21

2.  Clinical Significance of G Protein-Coupled Receptor 110 (GPR110) as a Novel Prognostic Biomarker in Osteosarcoma.

Authors:  Zhiqiang Liu; Guorong Zhang; Changlei Zhao; Juming Li
Journal:  Med Sci Monit       Date:  2018-07-27

3.  Prognostic factors to survival of patients with chondroblastic osteosarcoma.

Authors:  Hui-Hui Sun; Xiang-Yang Chen; Jia-Qu Cui; Zhao-Ming Zhou; Kai-Jin Guo
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889

Review 4.  Multiparametric MRI evaluation of bone sarcomas in children.

Authors:  Emilio J Inarejos Clemente; Oscar M Navarro; Maria Navallas; Enrique Ladera; Ferran Torner; Mariona Sunol; Moira Garraus; Jordi Català March; Ignasi Barber
Journal:  Insights Imaging       Date:  2022-03-01

5.  Diffusion-weighted imaging in differentiating mid-course responders to chemotherapy for long-bone osteosarcoma compared to the histologic response: an update.

Authors:  Céline Habre; Alexia Dabadie; Anderson D Loundou; Jean-Bruno Banos; Catherine Desvignes; Harmony Pico; Audrey Aschero; Nathalie Colavolpe; Charlotte Seiler; Corinne Bouvier; Emilie Peltier; Jean-Claude Gentet; Christiane Baunin; Pascal Auquier; Philippe Petit
Journal:  Pediatr Radiol       Date:  2021-04-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.